ADC Therapeutics
ADCT
#9013
Rank
HK$1.41 B
Marketcap
HK$10.03
Share price
-1.54%
Change (1 day)
-67.93%
Change (1 year)

EPS for ADC Therapeutics (ADCT)

EPS in 2026 (TTM): -HK$5.15

According to ADC Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$5.17. In 2025 the company made an earnings per share (EPS) of -HK$9.41 an increase over its 2024 EPS that were of -HK$12.93.

EPS history for ADC Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$5.15-45.2%
2025-HK$9.41-27.27%
2024-HK$12.93
2022-HK$15.76-33%
2021-HK$23.52-17.21%
2020-HK$28.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58 104.55%๐Ÿ‡บ๐Ÿ‡ธ USA